Intertumoral heterogeneity within medulloblastoma subgroups FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ... Cancer cell 31 (6), 737-754. e6, 2017 | 1039 | 2017 |
Subgroup-specific structural variation across 1,000 medulloblastoma genomes PA Northcott, DJH Shih, J Peacock, L Garzia, A Sorana Morrissy, ... Nature 488 (7409), 49-56, 2012 | 959 | 2012 |
The whole-genome landscape of medulloblastoma subtypes PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ... Nature 547 (7663), 311-317, 2017 | 948 | 2017 |
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy X Lan, DJ Jörg, FMG Cavalli, LM Richards, LV Nguyen, RJ Vanner, ... Nature 549 (7671), 227-232, 2017 | 420 | 2017 |
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis V Ramaswamy, M Remke, E Bouffet, CC Faria, S Perreault, YJ Cho, ... The lancet oncology 14 (12), 1200-1207, 2013 | 395 | 2013 |
Cytogenetic prognostication within medulloblastoma subgroups DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ... Journal of clinical oncology 32 (9), 886-896, 2014 | 356 | 2014 |
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis EM Thompson, T Hielscher, E Bouffet, M Remke, B Luu, S Gururangan, ... The lancet oncology 17 (4), 484-495, 2016 | 355 | 2016 |
Childhood cerebellar tumours mirror conserved fetal transcriptional programs MC Vladoiu, I El-Hamamy, LK Donovan, H Farooq, BL Holgado, ... Nature 572 (7767), 67-73, 2019 | 353 | 2019 |
Divergent clonal selection dominates medulloblastoma at recurrence AS Morrissy, L Garzia, DJH Shih, S Zuyderduyn, X Huang, P Skowron, ... Nature 529 (7586), 351-357, 2016 | 342 | 2016 |
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ... Acta neuropathologica 126, 917-929, 2013 | 199 | 2013 |
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ... Nature 553 (7686), 101-105, 2018 | 194 | 2018 |
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of Clinical Oncology 34 (21), 2468, 2016 | 187 | 2016 |
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma LK Donovan, A Delaidelli, SK Joseph, K Bielamowicz, K Fousek, ... Nature medicine 26 (5), 720-731, 2020 | 161 | 2020 |
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma H Suzuki, SA Kumar, S Shuai, A Diaz-Navarro, A Gutierrez-Fernandez, ... Nature 574 (7780), 707-711, 2019 | 147 | 2019 |
Spatial heterogeneity in medulloblastoma AS Morrissy, FMG Cavalli, M Remke, V Ramaswamy, DJH Shih, ... Nature genetics 49 (5), 780-788, 2017 | 140 | 2017 |
A hematogenous route for medulloblastoma leptomeningeal metastases L Garzia, N Kijima, AS Morrissy, P De Antonellis, A Guerreiro-Stucklin, ... Cell 172 (5), 1050-1062. e14, 2018 | 124 | 2018 |
Medulloblastoma subgroups remain stable across primary and metastatic compartments X Wang, AM Dubuc, V Ramaswamy, S Mack, DMA Gendoo, M Remke, ... Acta neuropathologica 129, 449-457, 2015 | 99 | 2015 |
Heterogeneity within the PF-EPN-B ependymoma subgroup FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ... Acta neuropathologica 136, 227-237, 2018 | 98 | 2018 |
Metabolic regulation of the epigenome drives lethal infantile ependymoma KA Michealraj, SA Kumar, LJY Kim, FMG Cavalli, D Przelicki, JB Wojcik, ... Cell 181 (6), 1329-1345. e24, 2020 | 89 | 2020 |
Failure of human rhombic lip differentiation underlies medulloblastoma formation LD Hendrikse, P Haldipur, O Saulnier, J Millman, AH Sjoboen, ... Nature 609 (7929), 1021-1028, 2022 | 69 | 2022 |